Clinical trial
Study of the Efficacy and Safety of Escitalopram for the Prevention of Depressive Episodes Induced by Peg-Interferon Alpha2a and Ribavirin in Chronic Hepatitis C Patients. Randomized, Double-Blind, Placebo-Controlled Clinical Trial
NCT00166296 is registered in ClinicalTrials.gov with Germans Trias i Pujol Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Efficacy and Safety of Escitalopram for the Prevention of Depressive Episodes Induced by Peg-Interferon Alpha2a and Ribavirin in Chronic Hepatitis C Patients. Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- Lead sponsor
- Germans Trias i Pujol Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- October 31, 2007
- Enrollment
- 133 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.